CD4 and severe combined immunodeficiency: In the IBD experimental model of severe combined immunodeficiency mice subjected to CD45RBhigh CD4+ T cell adoptive transfer, etrasimod significantly reduced the colonic inflammation indices and weight loss with respect to controls (Kühbacher et al., 2017).